These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

107 related articles for article (PubMed ID: 6523390)

  • 21. [Protective barrier of the gastric and duodenal mucosa in peptic ulcer].
    Masevich TsG; Karandashov GF; Sindalovskaia IS
    Klin Med (Mosk); 1980 Nov; 58(11):25-8. PubMed ID: 7005536
    [No Abstract]   [Full Text] [Related]  

  • 22. [Effect of 16, 16-dimethylprostaglandin E2 on the electrolyte barrier of the stomach in patients with peptic ulcer].
    Orzechowska R
    Pol Arch Med Wewn; 1983 Sep; 70(3):93-9. PubMed ID: 6657495
    [No Abstract]   [Full Text] [Related]  

  • 23. [Progress in research on anti-relapsing mechanism of Chinese herbal medicine in the treatment of peptic ulcer].
    Zhou FS; Hu L; Cui QZ
    Zhongguo Zhong Xi Yi Jie He Za Zhi; 2001 Mar; 21(3):232-4, 225. PubMed ID: 12577343
    [No Abstract]   [Full Text] [Related]  

  • 24. [Pharmacological vagotomy in treatment of peptic ulcer].
    Korshak AL; Kushnir VE
    Ter Arkh; 1977; 49(1):45-8. PubMed ID: 867239
    [No Abstract]   [Full Text] [Related]  

  • 25. [Hormonal homeostasis (somatotropin, thyrotropin, triiodothyronine and cortisol) and the histomorphologic indicators of the gastric mucosa during treatment with preparations enhancing protein synthesis (alvesin-new and retabolyl)].
    Korepanov AM; Gorbunov IuV
    Ter Arkh; 1987; 59(2):56-8. PubMed ID: 3576477
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Effect of anti-ulcer drugs on the contents of free amino acids in the mucosa of different parts of the stomach in experimental neurogenic dystrophy].
    Mirzoian SA; Tatevosian AT
    Zh Eksp Klin Med; 1974; 14(1):3-8. PubMed ID: 4154690
    [No Abstract]   [Full Text] [Related]  

  • 27. [Processes of cyclicity in the course of ulcer disease].
    Kornilova LS; Zhuk EG; Nikitin GA
    Klin Med (Mosk); 2002; 80(10):39-43. PubMed ID: 12471837
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Generation of prostaglandins in gastric mucosa of patients with peptic ulcer disease: effect of nonsteroidal antiinflammatory compounds.
    Konturek SJ; Obtulowicz W; Kwiecien N; Oleksy J
    Scand J Gastroenterol Suppl; 1984; 101():75-7. PubMed ID: 6599541
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Lipid peroxidation in the blood and tissues of patients with peptic ulcer].
    Morozov VP; Perelygin VG; Savranskiĭ VM; Shabunevich LV
    Klin Med (Mosk); 1992 Feb; 70(2):75-7. PubMed ID: 1507829
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Possibilities of predicting the effect of surgical vagotomy].
    Postolov PM; Naumov BA
    Vestn Khir Im I I Grek; 1974 Sep; 113(9):138-41. PubMed ID: 4154010
    [No Abstract]   [Full Text] [Related]  

  • 31. [Importance of acid secretion inhibition in peptic ulcer treatment].
    Med Clin (Barc); 1990 Mar; 94(8):suppl 2 p.. PubMed ID: 2342387
    [No Abstract]   [Full Text] [Related]  

  • 32. [Effect of various mixtures of anticholinergic agents on the functional state of the circulatory system in peptic ulcer].
    Ivanova EA
    Vrach Delo; 1977 Oct; (10):108-11. PubMed ID: 602112
    [No Abstract]   [Full Text] [Related]  

  • 33. Secreted and membrane-bound mucins and idiopathic peptic ulcer disease.
    Niv Y; Boltin D
    Digestion; 2012; 86(3):258-63. PubMed ID: 23075498
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Prostaglandin and cyclic nucleotide levels in patients with peptic ulcer and chronic gastritis with secretory insufficiency].
    Valenkevich LN; Zaĭchuk ASh
    Ter Arkh; 1987; 59(2):29-31. PubMed ID: 3472366
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Disorders of the bioenergetics and microcirculation in the gastric mucosa in peptic ulcer with concomitant involvement of the hepatobiliary system].
    Kolomoets MIu; Matvienko AV
    Lik Sprava; 1992 Apr; (4):30-4. PubMed ID: 1441365
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Krebs cycle, pentose phosphate pathway, and glycolysis in the uninvolved gastric mucosa of peptic ulcer and gastric cancer patients.
    Orwell RL; Piper DW
    Gastroenterology; 1977 Dec; 73(6):1320-5. PubMed ID: 913974
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Histological and histochemical changes in the gastric mucosa in peptic ulcer].
    Buinov BB; Strizhkov VS; Suvorova EG
    Vrach Delo; 1980 Oct; (10):73-4. PubMed ID: 7434711
    [No Abstract]   [Full Text] [Related]  

  • 38. [Methodology of investigations on the intestinal phase of gastric secretion depending on the methods for surgical treatment].
    Zaĭtsev VT; Boĭko VV; Taraban IA; Savvi SA
    Lik Sprava; 2001; (3):69-72. PubMed ID: 11560032
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Effects of carbenoxolone on gastric release of prostaglandin (PG)E2 in patients with peptic ulcer disease.
    Rask-Madsen J; Bukhave K; Madsen PE; Bekker C
    Acta Gastroenterol Belg; 1983; 46(9-10):419-28. PubMed ID: 6585111
    [No Abstract]   [Full Text] [Related]  

  • 40. Effect of pirenzepine on L--amino acids stimulated gastric acid secretion and serum gastrin levels in peptic ulcer disease in men.
    Bertoglio S; Anfossi A; Arnulfo G; Valentini P; Berti Riboli E
    Scand J Gastroenterol Suppl; 1982; 72():179-84. PubMed ID: 6957988
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.